LABMED Ships 65 Mil + Medical Masks 38 Mil Virus Transport Medium Kits Internationally

CathWorks FFRangio™ System Receives National Reimbursement Approval in Japan

CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System,...

Levine Leichtman Capital Partners Sells FlexXray

Levine Leichtman Capital Partners ("LLCP"), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company FlexXray Holdings, LLC ("FlexXray" or...

LBMED, a Singapore based company, reported today that they have shipped over 65 million masks worldwide. The company specializes in the manufacture of disposable civil mask, medical mask, surgical mask, KN95-FFP2 mask and other medical instruments.

LABMED is currently supplying these much-needed masks and medical devices to Singapore, the US State of Hawaii, the UK, Italy, Germany, India and South Africa.

LABMED has also shipped 38 million VTM (Virus Transport Medium) kits worldwide. These VTMs are a crucial part of the battle against Covid-19, as they are coupled with the nasal swab kits, and they hold the completed swabs that will be sent to laboratories for testing.

The demand for VTM nasal swabs kits and saliva collection kit is expected to rise with the current situation with most countries going through community testing, while the global face mask market is expected to register phenomenal growth by the end of 2020,” says LABMED’s Regional Managing Director, Wilson.

The prominence that LABMED plays in the fight against the Covid-19 pandemic has also guided how it gives back to the communities that are affected by this international crisis.

“As governments, NGOs and healthcare agencies respond to this pandemic, we thought about how to give back to our community.  Fortunately, we are in a good position to offer assistance, and we actively donate and contribute to the less fortunate so they are also taken care of during tough times like these when their financials are impacted,” shares Regional Managing Director, Wilson.

spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.